|
1
|
Kobayashi H, Sumimoto K, Kitanaka T,
Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, Kanayama S,
Shigetomi H, et al: Ovarian endometrioma-risks factors of ovarian
cancer development. Eur J Obstet Gynecol Reprod Biol. 138:187–193.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brinton LA, Sakoda LC, Sherman ME,
Frederiksen K, Kjaer SK, Graubard BI, Olsen JH and Mellemkjaer L:
Relationship of benign gynecologic diseases to subsequent risk of
ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev.
14:2929–2935. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nicklin J, Janda M, Gebski V, Jobling T,
Land R, Manolitsas T, McCartney A, Nascimento M, Perrin L, Baker
JF, et al: The utility of serum CA-125 in predicting extra-uterine
disease in apparent early-stage endometrial cancer. Int J Cancer.
131:885–890. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Taniguchi F, Harada T, Kobayashi H,
Hayashi K, Momoeda M and Terakawa N: Clinical characteristics of
patients in Japan with ovarian cancer presumably arising from
ovarian endometrioma. Gynecol Obstet Invest. 77:104–110. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tanase Y, Kawaguchi R, Takahama J and
Kobayashi H: Factors that differentiate between
endometriosis-associated ovarian cancer and benign ovarian
endometriosis with mural nodules. Magn Reson Med Sci. 17:231–237.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou Y and Hua KQ: Ovarian endometriosis:
Risk factor analysis and prediction of malignant transformation.
Prz Menopauzalny. 17:43–48. 2018.PubMed/NCBI
|
|
7
|
Yoshimoto C, Iwabuchi T, Shigetomi H and
Kobayashi H: Cyst fluid iron-related compounds as useful markers to
distinguish malignant transformation from benign endometriotic
cysts. Cancer Biomark. 15:493–439. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamaguchi K, Mandai M, Toyokuni S,
Hamanishi J, Higuchi T, Takakura K and Fujii S: Contents of
endometriotic cysts, especially the high concentration of free
iron, are a possible cause of carcinogenesis in the cysts through
the iron-induced persistent oxidative stress. Clin Cancer Res.
14:32–40. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yoshimoto C, Takahama J, Iwabuchi T,
Uchikoshi M, Shigetomi H and Kobayashi H: Transverse relaxation
rate of cyst fluid can predict malignant transformation of ovarian
endometriosis. Magn Reson Med Sci. 16:137–145. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nagai M, Mizusawa N, Kitagawa T and
Nagatomo S: A role of heme side-chains of human hemoglobin in its
function revealed by circular dichroism and resonance Raman
spectroscopy. Biophys Rev. 10:271–284. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iwabuchi T, Yoshimoto C, Shigetomi H and
Kobayashi H: Cyst fluid hemoglobin species in endometriosis and its
malignant transformation: The role of metallobiology. Oncol Lett.
11:3384–3388. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oh JY, Hamm J, Xu X, Genschmer K, Zhong M,
Lebensburger J, Marques MB, Kerby JD, Pittet JF, Gaggar A and Patel
RP: Absorbance and redox based approaches for measuring free heme
and free hemoglobin in biological matrices. Redox Biol. 9:167–177.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Colquhoun DA, Forkin KT, Durieux ME and
Thiele RH: Ability of the Masimo pulse CO-Oximeter to detect
changes in hemoglobin. J Clin Monit Comput. 26:69–73. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lopes-Coelho F, Gouveia-Fernandes S,
Gonçalves LG, Nunes C, Faustino I, Silva F, Félix A, Pereira SA and
Serpa J: HNF1β drives glutathione (GSH) synthesis underlying
intrinsic carboplatin resistance of ovarian clear cell carcinoma
(OCCC). Tumour Biol. 37:4813–4829. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harris IS, Treloar AE, Inoue S, Sasaki M,
Gorrini C, Lee KC, Yung KY, Brenner D, Knobbe-Thomsen CB, Cox MA,
et al: Glutathione and thioredoxin antioxidant pathways synergize
to drive cancer initiation and progression. Cancer Cell.
27:211–222. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kawahara N, Yamada Y, Ito F, Hojo W,
Iwabuchi T and Kobayashi H: Discrimination of malignant
transformation from benign endometriosis using a near-infrared
approach. Exp Ther Med. 15:3000–3005. 2018.PubMed/NCBI
|
|
17
|
Fischer R and Harmatz PR: Non-invasive
assessment of tissue iron overload. Hematology Am Soc Hematol Educ
Program. 215–221. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wood JC, Enriquez C, Ghugre N, Tyzka JM,
Carson S, Nelson MD and Coates TD: MRI R2 and R2* mapping
accurately estimates hepatic iron concentration in
transfusion-dependent thalassemia and sickle cell disease patients.
Blood. 106:1460–1465. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Argyropoulou MI and Astrakas L: MRI
evaluation of tissue iron burden in patients with beta-thalassaemia
major. Pediatr Radiol. 37:1191–1200. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Verlhac S, Morel M, Bernaudin F, Béchet S,
Jung C and Vasile M: Liver iron overload assessment by MRI R2*
relaxometry in highly transfused pediatric patients: An agreement
and reproducibility study. Diagn Interv Imaging. 96:259–264. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arakawa N, Kobayashi H, Yonemoto N,
Masuishi Y, Ino Y, Shigetomi H, Furukawa N, Ohtake N, Miyagi Y,
Hirahara F, et al: Clinical Significance of tissue factor pathway
inhibitor 2, a serum biomarker candidate for ovarian clear cell
carcinoma. PLoS One. 11:e01656092016. View Article : Google Scholar : PubMed/NCBI
|
